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Abstract Understanding the pathogenicity of amyloid-beta
(Ab) peptides constitutes a major goal in research on
Alzheimer’s disease (AD). One hypothesis entails that Ab
peptides induce uncontrolled, neurotoxic ion flux through
cellular membranes. The exact biophysical mechanism of this
ion flux is, however, a subject of an ongoing controversy
which has attenuated progress toward understanding the
importance of Ab-induced ion flux in AD. The work presented
here addresses two prevalent controversies regarding the
nature of transmembrane ion flux induced by Ab peptides.
First, the results clarify that Ab can induce stepwise ion flux
across planar lipid bilayers as opposed to a gradual increase in
transmembrane current; they show that the previously repor-
ted gradual thinning of membranes with concomitant increase
in transmembrane current arises from residues of the solvent
hexafluoroisopropanol, which is commonly used for the
preparation of amyloid samples. Second, the results provide
additional evidence suggesting that Ab peptides can induce
ion channel-like ion flux in cellular membranes that is inde-
pendent from the postulated ability ofAb to modulate intrinsic
cellular ion channels or transporter proteins.
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Introduction
One of the current hypotheses for the pathology of
Alzheimer’s disease (AD) proposes that amyloid-beta (Ab)
peptides induce aberrant, neurotoxic ion flux across cellular
membranes (Koh et al. 1990; Arispe et al. 1993a, b;
Kawahara et al. 2000; Kourie et al. 2001; Michikawa et al.
2001; Arispe and Doh 2002; Kurganov et al. 2004; Barghorn
et al. 2005; Quist et al. 2005; Baglioni et al. 2006; Devi et al.
2006; Morris and Juranka 2007; Palop et al. 2007; Simakova
and Arispe 2007; Bezprozvanny and Mattson 2008). The
resulting difficulty of neurons to regulate their intracellular
concentration of ions, in particular calcium ions, has been
associated with cell death (Khachaturian 1987; Mattson et al.
1992) and may thus contribute to cognitive impairment
typical for AD. Understanding the underlying mechanisms
that cause Ab-induced ion flux may hence be crucial for
developing new strategies to reduce the toxicity of Ab in AD
(Inbar and Yang 2006; Inbar et al. 2006; Stains et al. 2007).
Increasing evidence shows that exposure of cells to Ab
leads to elevated concentrations of intracellular calcium
ions (Khachaturian 1987, 1989; Mattson et al. 1992; Arispe
et al. 1993b; Pollard et al. 1993; Kawahara et al. 2000;
Mattson and Chan 2003; Demuro et al. 2005; Tu et al.
2006; Stutzmann 2007; Cheung et al. 2008; Nimmrich
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et al. 2008); the predominant cellular mechanism for this
disruption of Ca2? homeostasis remains, however, a focus
of intense studies. The four mechanisms that have been
proposed are (1) Ab assembles into oligomers to form Ab
ion channels in cell membranes (Arispe et al. 1993a, b,
1996, 2007, 2008; Pollard et al. 1993; Durell et al. 1994;
Mirzabekov et al. 1994; Kawahara et al. 1996, 1997; Rhee
et al. 1998; Hirakura et al. 1999a, b; Lin et al. 1999, 2001;
Zhu et al. 2000; Kourie et al. 2001, 2002; Kagan et al. 2002,
2004; Lin and Kagan 2002; Bahadi et al. 2003; Arispe 2004;
Micelli et al. 2004; Mobley et al. 2004; Quist et al. 2005;
Lal et al. 2007; Jang et al. 2008), (2) Ab interacts with
membranes in such a way that it generally lowers the
dielectric barrier for ions to cross the membrane (e.g. by
thinning the membrane) (Kayed et al. 2004; Sokolov et al.
2004, 2006), (3) Ab modulates, directly or indirectly, the
activity of existing ion channel proteins or receptors
(Yankner et al. 1990a, b; Joslin et al. 1991; Mark et al. 1995;
Querfurth et al. 1997; Ueda et al. 1997; Ye et al. 1997;
Morimoto et al. 1998; Wang et al. 2000; Rovira et al. 2002;
Dougherty et al. 2003; Novarino et al. 2004; Verdier et al.
2004; Deshpande et al. 2006; Stutzmann et al. 2006, 2007;
Cheung et al. 2008; Dreses-Werringloer et al. 2008; Fed-
rizzi et al. 2008; Lopez et al. 2008; Nimmrich et al. 2008),
or (4) Ab modulates, directly or indirectly, the activity of
cellular ion transporters and pumps (Lam et al. 2001; Green
et al. 2008). Experimental evidence for each of these
mechanisms has been provided and it is possible that sev-
eral mechanisms act together to disrupt Ca2? homeostasis.
The work presented here examined the first three
mechanisms. It employed electrophysiological techniques
to measure ion flux by current recordings across bilayer
lipid membranes (using BLM recordings) or across cellular
plasma membranes (using whole-cell patch clamp record-
ings). This approach excluded the study of ion flux by
transporter proteins or ion pumps because the ion flux
generated by these proteins is too slow to be detectable by
current recordings (Gennis 1989). Instead, we asked if Ab
can form ion pores in artificial lipid bilayers, in membranes
of a human neuronal cell line (SH-SY5Y), and in primary
neurons from transgenic mice that generate Ab intrinsically
by expressing human amyloid precursor protein (hAPP)
and human presenilin 1 (hPS-1).
Materials and Methods
Chemicals
We purchased Ab(1-40) and Ab(1-42) from Biopeptides
Inc. and from Bachem Inc., hexafluoroisopropanol (HFIP)
(GC grade) from Fluka, and the following seven lipids from







[phospho-rac-(1-glycerol)] (POPG). All other chemicals
were purchased from Sigma–Aldrich; SH-SY5Y cells were
obtained from ATCC.
Preparation of Solutions of Ab by Purging HFIP
with Nitrogen Gas
We prepared samples of Ab by following exactly a previ-
ously reported protocol (Kayed et al. 2003, 2004; Sokolov
et al. 2004, 2006; Demuro et al. 2005). Briefly, we dissolved
1 mg of Ab peptide in 400 ll of HFIP and incubated this
solution for 15 min. We mixed 100 ll of the resulting, clear
Ab solution in HFIP with 900 ll of deionized water in a
siliconized 1.5 ml microtube. After incubation at room
temperature for 15 min, we centrifuged the samples for
15 min at 14,000g and transferred the supernatant fraction
(900–950 ll) to a new siliconized tube. To purge HFIP
from these samples, we bubbled nitrogen gas for 10 min
through these samples, while adjusting the gas flow to
*30 ml min-1, which was the maximum flow rate that did
not result in excessive foaming and splashing of the sample.
For purging times longer than 10 min, we had to reduce the
flow rate of the N2 gas to 2–3 ml min
-1 in order to avoid
significant loss of material due to slow but steady accu-
mulation and expulsion of foam from the sample. We
analyzed aliquots of these samples for residual HFIP con-
centration by gas chromatography-mass spectrometry (GC-
MS) and tested their ability to induce transmembrane ion
flux in planar lipid bilayers and cell membranes.
Quantification of HFIP Concentrations by GC-MS
Analysis
This analysis was carried out by injecting a sample volume of
2 ll into a Finnigan Trace GC-MS with the following set-
tings: run in electron impact ionization mode using a 30 m
long, 0.25 mm ID Supelco SLB-5 column, with a film
thickness of 0.25 lm. Helium was used as carrier gas at a
constant flow rate of 1.0 ml min-1; the injector temperature
was 200C; the run was performed in split mode with a ratio
of 1:100; the interface temperature was 250C, and the ion
source block temperature was 220C. The temperature of the
GC oven was held at 40C for 2 min and then increased to
150C at a rate of 40C min-1. The MS ion source filament
was set to an emission current of 150 lA at 70 eV. HFIP
standards and calibration curves were generated each day.
Samples with unknown HFIP concentrations were measured
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using an external calibration curve; no internal standards
were used. The quantification was based on the area under
the GC peak in the chromatogram. Data were acquired and
processed using Excalibur software, version 1.1.
Formation of Planar Lipid Bilayers
The two reported original procedures (Arispe et al. 1993b;
Kayed et al. 2003) that are at the basis of the controversy
regarding the nature of Ab-induced ion flux across artificial
lipid membranes employed different methods to generate
planar lipid bilayers (Arispe et al. 1993b; Kayed et al.
2004). We, therefore, prepared planar lipid bilayers [also
called black lipid membranes or bilayer lipid membranes
(BLMs)] either by the so-called ‘‘folding technique’’
(Montal and Mueller 1972; Mayer et al. 2003; Capone et al.
2007; Blake et al. 2008), which employs apposition of lipid
monolayers over a pore with a diameter of *150 lm in a
Teflon film or by the so-called ‘‘painting technique’’
(Mueller et al. 1962; Capone et al. 2007), which applies a
solution of lipids in decane or heptane over a pore with a
diameter of *250 lm in a Delrin septum.
For the folded bilayers (Figs. 1 and 2b columns
DOPC ? DOPE and DiPhyPC), we pretreated the Teflon
film with 2 ll of 5% (v/v) squalene in pentane and then
formed the bilayers using 5 ll of either pure DiPhyPC or a
1:1 (w/w) mixture of a lipid solution in pentane that con-
tained DOPC and DOPE. The total lipid concentration of
these solutions in pentane was 20–25 mg ml-1 (Capone
et al. 2007; Mayer et al. 2008). The electrolyte contained
70 mM KCl buffered with 10 mM HEPES, pH 7.4.
For the painted bilayers, we used a bilayer cup (Warner
Instruments, Delrin perfusion cup, volume 1 ml) and the
following four lipid mixtures at a 1:1 (w/w) ratio: POPG:
POPE in heptane, DOPS:POPE in heptane, DOPC:DOPE in
heptane, or POPE:POPS in decane. The total lipid concen-
tration of these solutions in heptane or decane was 10–20
mg ml-1. In order to promote fusion of Ab proteoliposomes
into bilayers, we used an ionic gradient formed by filling the
cis side (the side of proteoliposome addition) with 370 mM
KCl and the trans side of the bilayer setup with 70 mM KCl.
For these experiments, we prepared bilayers using a 1:1 (w/w)
mixture of DOPC and DOPE (Fig. 1d) or POPC and POPE
(Fig. 4a–c); the proteoliposomes containing Ab were pre-
pared as described previously using either a 1:1 (w/w) mixture
of DOPC and DOPE lipids (Fig. 1d) or pure POPS lipids
(Fig. 4a, b and Fig. 5a) (Arispe et al. 1993b).
Incorporation of Ab into Lipid Membranes
In order to repeat the procedure for preparing Ab samples
that was previously described to lead to membrane thinning
of planar lipid bilayers (Kayed et al. 2004; Sokolov et al.
2004, 2006; Demuro et al. 2005), we prepared Ab samples
by using the solvent HFIP exactly as described (Kayed et al.
2003) and added the resulting solutions to both compart-
ments of the bilayer chamber. We diluted these samples
more than 50-fold such that the final concentration of Ab
was 0.5–2.0 lM in each chamber of the bilayer setup.
In order to repeat the alternative Ab procedure, which
was previously described to lead to stepwise ion flux across
planar lipid bilayers (Arispe et al. 1993b), we added
10–20 ll of the Ab proteoliposome solution (this solution
contained Ab at a concentration of 0.4–0.8 mg ml-1) to the
cis compartment (volume 1 ml) and stirred for 5–10 min.
Planar lipid bilayer experiments with each lipid com-
position were performed at least 3 times, more typically
5–7 times.
Current Recordings
Before carrying out bilayer recordings, we verified that
both the painted and the folded bilayers were stable for
several minutes (while applying a voltage of at least
±100 mV) and that the membrane capacitances were
above 90 pF. When both criteria were fulfilled, we added
Ab (0.5–4.0 lM final concentration of Ab) or HFIP (0.5–
7.0 mM final concentration of HFIP without any Ab
present) to both chambers of the bilayer setup.
We performed all recordings in ‘‘voltage clamp mode’’
using Ag/AgCl electrodes. We used a filter-cutoff fre-
quency of 2 kHz, and a sampling frequency of 15 kHz for
all bilayer recordings. For representation in figures, we
filtered the current traces with a digital Gaussian low-pass
filter with a cutoff frequency of 100 Hz.
For whole-cell patch clamp recordings, we used the
following three solutions: (1) intracellular solution con-
taining 75 mM KCl, 10 mM NaCl, 70 mM KF, 2 mM
MgCl2, 10 mM EGTA, and 10 mM HEPES buffer (pH 7.2);
(2) extracellular solution containing 160 mM NaCl,
4.5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 5 mM D-glu-
cose, and 10 mM HEPES buffer (pH 7.4); and (3) a ‘‘seal
enhancer’’ solution containing 80 mM NaCl, 3 mM KCl,
10 mM MgCl2, 35 mM CaCl2 and 10 mM HEPES/NaOH
(pH 7.4), which was added to the extracellular compartment
to promote the formation of seals between the cells and the
glass chip with electrical resistances higher than 1 GX.
In order to introduce Ab into membranes of SH-SY5Y
cells, we first established whole-cell recording conditions
followed by adding *5 ll of extracellular solution con-
taining Ab to a volume of *20 ll of extracellular solution
(this Ab solution was prepared without the use of HFIP by
dissolving Ab in extracellular solution and stirring this
solution for *14 h at room temperature prior to use). The
final concentration of Ab in the extracellular solution
during the recording was *10 lM.
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In order to measure the effect of Ab and HFIP samples on
SH-SY5Y cells or on primary neurons, we used a semi-
automated, chip-based electrophysiology instrument (Port-a-
patch, Nanion Inc.) that allowed for recordings with seal
resistances of 1–6 GX (Schmidt et al. 2000; Bruggemann et al.
2003; Estes et al. 2008). We held the voltage at -80 mV in the
intracellular compartment versus ground in the extracellular
compartment to measure Ab-induced ion flux. At this poten-
tial, SH-SY5Y cells did not show significant intrinsic ion
channel activity. Samples containing Ab or HFIP were only
added after confirming the stability of the recording (i.e., after
observing a quiescent baseline for 3–5 min). For all whole-
cell recordings, we used a filter cutoff frequency of 1 kHz.
In order to determine the effect of Zn2? ions or the
peptide NA7 on Ab-induced transmembrane ion flux, we
added 1–10 mM (final concentration) of ZnCl2 or Zn(NO3)2
or 100–140 lM (final concentration) of the NA7 peptide to
the bilayer chambers or to the extracellular solutions.
Preparation of Primary Neurons
Wild-type female mice (C57BL/6J) were crossed with
double transgenic hAPPswe/hPS-1DE9 male mice, obtained
from Jackson Laboratory (Bar Harbor, Maine) to generate
wild-type, and hAPPswe/hPS-1 transgenic embryos. Pri-
mary cortical neuron cultures were prepared from the brains
of E16 embryos. Briefly, the cerebral cortices were dis-
sected in calcium-free and magnesium-free Hank’s
balanced salt solution and incubated with a 0.125% trypsin
solution for 10 min at 37C. The trypsin was inactivated
with Dulbecco’s modified Eagle’s medium containing 10%
fetal bovine serum, and the cortical tissue was further dis-
sociated by serial trituration using a Pasteur pipette. The
resulting cell suspensions were diluted in neurobasal med-
ium supplemented with B27 supplements (Gibco BRL,
Grand Island, New York), and plated onto poly-D-lysine-
coated Petri dishes. Neurons were maintained at 37C in a
5% CO2 atmosphere for 4–7 days, before the experiments
(Saluja et al. 2006). We carried out the planar patch clamp
experiments (on the Port-a-patch instrument) between day 4
and day 7 of culture. The neurons were detached using a
protocol previously described and validated by Lecoeur
et al. (2004) with minor modifications; these modifications
entailed (1) reducing the incubation time with trypsin-
EDTA from 15 to 14 min at 37C and (2) dissociating cell
aggregates by increasing the number of successively aspi-
rating and dispensing the cell suspension to 7 times with a
1 mL pipette tip and to 15 times with a 200 ll pipette tip.
Cytotoxicity Assay of HFIP with SH-SY5Y Cells
We cultured SH-SY5Y human neuroblastoma cells in
DMEM/F-12 (1:1) medium with 10% fetal bovine serum,
4 mM glutamax, penicillin (100 units ml-1) and strepto-
mycin (100 lg ml-1) in 5% CO2 at 37C. We plated cells
in 96-well plates overnight starting with 50,000 cells
well-1. After overnight incubation at 37C, we exchanged
the media with OptiMEM, and treated cells for 24 h. We
determined the cell viability using an MTT toxicology kit
(Tox-1, from Sigma) according to the instructions from the
supplier.
Results and Discussion
Recently, three articles highlighted an ongoing contro-
versy with regard to the exact biophysical characteristics
of Ab-induced transmembrane ion flux across artificial
lipid membranes (Eliezer 2006; Fagan et al. 2006; Marx
2007). These articles debate two mechanistic hypotheses.
On the one hand, the ‘‘Ab ion channel hypothesis’’ sug-
gests that Ab assembles into pore-like structures in lipid
membranes, leading to stepwise (or spike-like) fluctua-
tions of transmembrane current that is typical for ion
channels (Arispe et al. 1993a, b, 1996, 2007, 2008; Durell
et al. 1994; Mirzabekov et al. 1994; Kawahara et al. 1996,
1997; Rhee et al. 1998; Hirakura et al. 1999a, b; Lin et al.
1999, 2001; Bhatia et al. 2000; Zhu et al. 2000; Kourie
et al. 2001; Kagan et al. 2002, 2004; Kourie et al. 2002;
Lin and Kagan 2002; Bahadi et al. 2003; Arispe 2004;
Micelli et al. 2004; Quist et al. 2005; Lal et al. 2007; Jang
et al. 2008). On the other hand, the ‘‘Ab membrane
thinning hypothesis’’ postulates a generalized and gradu-
ally increasing ion flux as a result of Ab-induced
reduction of the dielectric barrier of membranes, for
instance, by thinning of membranes (Kayed et al. 2004;
Sokolov et al. 2004, 2006).
Here, we examined, in detail, the two pivotal proto-
cols for measuring Ab-induced conductance through
artificial lipid bilayers to resolve this controversy. The
protocol that leads to ion flux by gradual membrane
thinning involves solubilizing Ab(1-40) or Ab(1-42) in
the solvent hexafluoroisopropanol (HFIP), followed by
dilution in water, and purging of HFIP by a stream of
nitrogen gas (Kayed et al. 2003, 2004; Sokolov et al.
2004, 2006; Demuro et al. 2005; Valincius et al. 2008).
Figure 1a shows the gradual increase in ion flux through
a planar lipid bilayer upon exposure of membranes to
these Ab samples. Figure 1a is consistent with previous
reports that used the same HFIP-based experimental
procedure (Kayed et al. 2004; Sokolov et al. 2004,
2006). Figure 1b, however, shows a similar gradual
increase in conductance following the exact same pro-
tocol but in the absence of Ab. This control experiment
thus shows that Ab was not required for the observed
gradual increase in transmembrane conductance but that
4 Neurotox Res (2009) 16:1–13
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residues of HFIP alone could be responsible for the
observed ion flux.1
In order to investigate whether this gradual increase in
conductance could be reproduced by exposure of mem-
branes to defined concentrations of HFIP (in the absence of
Ab), we examined the effect of HFIP on cell membranes
(Fig. 1b inset) and on planar lipid bilayers of various lipid
compositions (Fig. 2a, b). We found that, in all of these
membranes, solutions containing 1–6 mM (corresponding
to 0.01–0.06% v/v) concentrations of HFIP induced a
gradual increase in ion flux similar to the results shown in
Fig. 1b and similar to results described previously (Kayed
et al. 2004; Sokolov et al. 2004, 2006).2 Since HFIP
induced a significant, gradual increase in transmembrane
ion flux in all tested membranes, we investigated its tox-
icity on SH-SY5Y cells using the MTT viability assay. We
found that HFIP was toxic to SH-SY5Y cells in a dose-
dependent manner: a concentration of HFIP of *30 mM
(*0.3% v/v) reduced the viability of SH-SY5Y cells to
50% (Fig. 3). At HFIP concentrations above *60 mM
(*0.6% v/v), we observed a 90% reduction in viability
of these cells.3 Based on these results, we emphasize that it
is critically important to remove HFIP completely before
attempting to investigate the effect of Ab, or other samples
prepared with HFIP, on cytotoxicity or on bilayer
membranes.
In order to examine the contribution of HFIP to the
reported transmembrane ion flux across lipid bilayers in
detail, we determined the residual concentration of HFIP
after purging Ab samples (Fig. 2c). In the previously
described protocol of preparing Ab samples by purging of
Fig. 1 Comparison of ion flux across lipid bilayers upon exposure to
samples of amyloid-b peptides (Ab), which were prepared by two
different protocols (final Ab concentration 1 lM). a Gradual increase
in transmembrane ion flux upon addition of an Ab sample that was
prepared by purging the solvent hexafluoroisopropanol (HFIP) for
10 min (Kayed et al. 2004; Sokolov et al. 2004). The ‘‘noisy’’ part of
the current trace is a result of stirring. b Gradual increase in
transmembrane ion flux following the exact same protocol as in (a)
but in the absence of Ab. Inset shows gradual increase in ion flux
across the membranes of SH-SY5Y cells upon addition of HFIP (final
concentration *6 mM). c Transmembrane ion flux upon addition of
an Ab sample prepared according to previous reports (Kayed et al.
2004; Sokolov et al. 2004) but with 18 h instead of 10 min of purging
to remove HFIP. d Stepwise fluctuations in transmembrane ion flux
after incorporating a proteoliposome preparation of Ab that was
prepared without using HFIP (Arispe et al. 1993b). The applied
voltage was -150 mV in all recordings. Membranes were prepared
from DOPC:DOPE lipids at a 1:1 (w/w) ratio by the ‘‘folding
method’’ over a pore with a diameter of 150 lm in a Teflon film that
was pretreated with 5% squalene in pentane
1 One of the previously reported results that supported the hypothesis
of Ab-induced gradual thinning of membranes was the observation
that an anti-Ab antibody could reduce the observed transmembrane
ion flux caused by these Ab preparations. These experiments were
carried out with Ab samples that were also prepared with an HFIP
purging protocol (Kayed et al. 2003, 2004; Sokolov et al. 2004, 2006).
We repeated this experiment with the modification that we added
bovine serum albumin (BSA) instead of adding an anti-Ab antibody.
In approximately half of these trials, we found a reduction in
transmembrane ion flux by adding BSA to the bilayer chamber. The
results were thus similar to the effect attributed previously to the anti-
Ab antibody. Furthermore, when we induced transmembrane ion flux
by adding HFIP only, we observed again a reduction in conductance
by addition of BSA to bilayer chambers that did not contain Ab.
These results suggest that a specific anti-Ab antibody was not
required to reduce gradually increasing ion flux that was induced by
samples containing HFIP.
2 These results together with previous work (Ennaceur and Sanderson
2005) show that even low concentrations of HFIP can adversely affect
membranes and alter their permeability for ions. Unlike other short
chain alcohols, HFIP affects membranes similarly as long chain
alcohols (Gutknecht and Tosteson 1970; Ueda and Yoshida 1999;
Ebihara et al. 1979).
3 For comparison, the ethanol concentration necessary to achieve
similar cell toxicity is higher than 200 mM (Luo and Miller 1997).
Neurotox Res (2009) 16:1–13 5
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HFIP (Kayed et al. 2003, 2004; Sokolov et al. 2004, 2006;
Demuro et al. 2005; Valincius et al. 2008), the Ab samples
were subjected to a gentle stream of N2 gas for 5–10 min.
We found by gas chromatography and mass spectrometry
(GC-MS) analysis of Ab samples prepared in the same
fashion that the residual concentrations of HFIP exceeded
200 mM in the Ab samples (Fig. 2c) even after purging for
30 min at a flow rate of 2–3 ml min-1 or after purging for
10 min at a fast flow rate of *30 ml min-1 (purging times
longer than 10 min at this fast flow rate were not practical
since they led to loss of Ab by excessive foam formation).
Addition of these Ab samples to planar lipid bilayers or to
cell membranes led to a gradual increase in transmembrane
ion flux that was similar to the one shown in Fig. 1b (the
final concentration of HFIP in the bilayer chamber ranged
from 5 to 20 mM). These results suggest that the reported
gradual increase in conductance (Kayed et al. 2004;
Sokolov et al. 2004, 2006) was due to incomplete removal
of residual HFIP in these Ab samples.
In contrast, when we purged HFIP from Ab samples for
18 h, we found that (1) the residual concentration of HFIP
in the Ab samples was consistently below 10 mM and (2)
that addition of these Ab samples to membranes (which
resulted in a final concentration of HFIP below 0.2 mM)
did not result in a gradual increase in ion flux. Instead, we
observed in *75% of these experiments a stepwise ion
flux as reported previously by several research groups
(Fig. 1c) (Arispe et al. 1993a, b, 1996, 2007, 2008; Mirz-
abekov et al. 1994; Kawahara et al. 1996; Rhee et al. 1998;
Hirakura et al. 1999a, b; Lin et al. 1999, 2001; Bhatia et al.
2000; Kourie et al. 2001; Kagan et al. 2002, 2004; Kourie
et al. 2002; Lin and Kagan 2002; Bahadi et al. 2003;
Fig. 2 Transmembrane ion flux induced by samples containing well-
defined concentrations of HFIP as well as removal of HFIP from Ab
samples as a function of the time of purging with nitrogen gas. a
Current versus voltage curves of transmembrane ion flux as a function
of HFIP concentration (Ab was not present in these experiments). The
slopes of the linear best fits represent the conductance (in Siemens,
S = X-1) of ions across a planar lipid bilayer made from a 1:1 (w/w)
mixture of DOPS and POPE. The absolute magnitudes of these
conductance values varied between repeated experiments and
between different membrane compositions; however, the relative
dose-dependent effect of increasing concentration of HFIP on the
conductance remained the same. b Transmembrane conductance
induced by 1 mM HFIP (equivalent to 0.01% v/v) in planar lipid
bilayers of various lipid compositions and by *6 mM HFIP in cell
membranes. All indicated lipid mixtures were prepared in a 1:1 (w/w)
ratio. All experiments were repeated at least three times; the error bars
represent the standard deviation from the mean conductance. c
Removal of HFIP from samples containing 100 ll of HFIP and
900 ll of water (concentration of HFIP *1 M) as a function of
purging time with nitrogen gas. The data indicated by red circles
correspond to a flow rate of N2 gas of *30 ml min
-1. The data
indicated by black squares correspond to a flow rate of 2–3 ml min-1.
All points represent average values (±standard deviation) from 2 to 6
repeated experiments. Note, for purging times longer than 10 min
with a flow rate of *30 ml min-1, we observed that significant
amounts of the foam that formed during purging escaped the
microtube, thus rendering this fast flow rate impractical for purging
times longer than 10 min
c
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Micelli et al. 2004; Quist et al. 2005).4 These ion channel-
like current fluctuations were reminiscent of the originally
reported Ab-induced transmembrane ion flux that led to the
Ab ion channel hypothesis in AD (Arispe et al. 1993b;
Pollard et al. 1993). For comparison, Fig. 1d shows such
stepwise current fluctuations through planar lipid bilayers
using the original protocol for preparation of Ab samples
(Arispe et al. 1993b) that did not employ HFIP (or that used
a protocol for preparation of Ab samples, which removed
HFIP completely by lyophilization for 2 days prior to
dissolving Ab in aqueous solution).
The results presented here, along with evidence from
other groups (Arispe et al. 1993a, b, 1996, 2007, 2008;
Mirzabekov et al. 1994; Kawahara et al. 1996, 1997; Rhee
et al. 1998; Hirakura et al. 1999a, b; Lin et al. 1999, 2001;
Bhatia et al. 2000; Zhu et al. 2000; Kourie et al. 2001,
2002; Kagan et al. 2002, 2004; Lin and Kagan 2002;
Bahadi et al. 2003; Arispe 2004; Micelli et al. 2004; Quist
et al. 2005; Lal et al. 2007; Jang et al. 2008), clearly
demonstrate that Ab peptides are indeed capable of form-
ing ion pores in artificial membranes. They also show that
stepwise ion flux is the predominant mode of ion flux
across artificial bilayers provided that the samples of Ab
are free of organic solvent. If gradual thinning would be the
predominant mechanism of Ab-induced ion flux, then we
would have expected to detect a gradual shift of the
recorded current baseline under the same conditions where
we observe measurable stepwise ion flux. Since all solvent-
free Ab preparations that we tested did not lead to gradual
shifts in current baseline, we conclude that the postulated
effect of Ab to lower the dielectric barrier by gradual
thinning of membranes—if existent—is small compared to
the ion flux induced by Ab pores. We also note that, to the
best of our knowledge, all reports that observed gradual
membrane thinning employed Ab samples that were pre-
pared with HFIP in combination with relatively short
durations of purging (\30 min) by a gentle gas stream
(Kayed et al. 2004; Sokolov et al. 2004, 2006). We,
therefore, attribute the reported gradual increase in ion flux
to residual HFIP in Ab samples. This conclusion resolves
the controversy with regard to Ab-induced ion flux across
artificial lipid bilayers; the results presented here confirm
that Ab can form ion pores in bilayer membranes.
After establishing the stepwise nature of Ab-induced ion
flux through planar lipid bilayers, two questions remain: (1)
Can Ab form ion pores in cellular membranes? (2) What is
the predominant mechanism of Ab-induced ion flux across
these cellular membranes? These questions are difficult to
answer definitively because of the many direct and indirect
pathways that can lead to ion flux in living cells. Here, we
provide additional evidence in support of the hypothesis
that Ab is capable of forming independent pores in cellular
membranes (Kawahara et al. 1997).
In order to compare ion flux induced by Ab in artificial
lipid bilayers with Ab-induced ion flux across cellular
membranes, we performed whole-cell patch clamp
recordings on a human neuroblastoma cell line (SH-SY5Y
cells) that we exposed to an exogenously introduced Ab
preparation (prepared after completely removing HFIP by
lyophylization for 2 days). In addition, we carried out
whole-cell recordings from transgenic, primary neurons
that produced Ab endogenously. In both cell types, we
performed all recordings close to the resting membrane
potential of the cells (i.e., at a constant applied voltage of
-80 mV) in order to minimize the activity of voltage-gated
ion channel proteins that are naturally (endogenously)
expressed in cells.
Figure 4 shows stepwise (or spike-like) Ab-induced
transmembrane ion flux in both cell types, regardless of
whether Ab was added exogenously to SH-SY5Y cells
(Fig. 4d) or produced endogenously by transgenic primary
neurons (Fig. 4g). It also demonstrates that both cell types
showed no (or very rare) current fluctuations in the
absence of Ab (Fig. 4f, i). We performed 16 recordings of
Ab-induced, channel-like ion flux on SH-SY5Y cells and
observed ion flux in 12 experiments (*75%), while addi-
tion of Ab induced no changes in ion flux in the remaining
4 experiments. Typically, Ab-induced current spikes
occurred 5–15 min after addition of Ab, but in at least one
recording the activity started within less than 30 s, sug-
gesting that Ab can induce a measurable current flux quite
rapidly.
Fig. 3 Viability of human SH-SY5Y neuroblastoma cells as a function
of overnight exposure to various increasing concentrations of HFIP.
Data are represented relative to control cells that were treated the same
way but without HFIP (corresponding to 100% viability). The solid
curve represents a best fit to a first order exponential decay function
of the form: Viability (%) = 100% 9 e-([HFIP] in mM/(41.2 ± 1.2) mM),
N = 13, R2 = 0.91
4 In the remaining *25% of the trials, we observed a flat baseline
without any detectable transmembrane current.
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In the case of the primary transgenic neurons, we
recorded from eight cells that were extracted from three
different transgenic embryos; seven of these recordings
(*88%) showed a significant increase in the frequency of
current spikes (Fig. 4g) compared to control recordings
from wild-type neurons (Fig. 4i). Only 1 of 11 control
recordings from primary, wild-type neurons showed a
frequency in current fluctuations similar to transgenic
neurons; the other 10 control cells displayed a signifi-
cantly lower frequency of current spikes than transgenic
neurons.
Since Zn2? ions have previously been reported to block
Ab-induced stepwise ion flux (Arispe et al. 1996; Kawa-
hara et al. 1997; Rhee et al. 1998; Lin et al. 1999; Kourie
et al. 2001; Lin and Kagan 2002; Kagan et al. 2004), we
added Zn2? to determine its effect on the observed current
fluctuations. In both, the SH-SY5Y and the transgenic
cells, addition of Zn2? reduced Ab-induced ion flux sig-
nificantly (Fig. 4e, h). The inhibitory effect of Zn2? in
these two cell types was similar to the Zn2?-induced
inhibition of Ab-induced, stepwise ion flux through artifi-
cial lipid bilayers (Fig. 4b).
As mentioned above, control experiments, in which Ab
was neither introduced exogenously nor produced endoge-
nously, did not result in significant stepwise or spike-like
ion flux under the same experimental conditions (Fig. 4f, i),
indicating that Ab was required to induce measurable ion
flux across cellular membranes. These results hence pose
the question: Did this measurable ion flux result from
activation of endogenous, cellular ion channel proteins or
was it a consequence of self-assembly of Ab to pores in
cellular membranes?
A comparison of Ab-induced ion flux (Fig. 5) revealed
that the average duration of stepwise (spike-like) current
fluctuations was significantly longer in bilayer experiments
than in cellular recordings (although bilayer experiments
also revealed short-lived events). In contrast, the duration
of Ab-induced current events was similar in SH-SY5Y
cells compared to transgenic primary neurons. The fre-
quency of large-amplitude current events (i.e., events that
were larger than four times the standard deviation of the
current noise) ranged from 0.2 to 5 Hz in SH-SY5Y and in
transgenic cells to*10 Hz in bilayer experiments and was,
thus, similar in magnitude. The single channel conductance
Fig. 4 Comparison of Ab-induced transmembrane ion flux across
planar lipid bilayers, across plasma membranes of a neuroblastoma
cell line, and across plasma membranes of primary cortical neurons
from mouse embryos. a Ab-induced ion flux across a planar lipid
bilayer (1:1 w/w POPC:POPE). Ab was introduced by proteolipo-
some fusion (final concentration of Ab = 1 lM). The applied
potential was ?30 mV or -30 mV as indicated. b Effect of the
addition (arrow) of *3 mM Zn2? on the same membrane as in (a).
The small vertical arrows indicate the beginning and end of mixing. c
Control experiment with a membrane of the same composition as in
(a) and (b) but without Ab present. d Whole-cell planar patch clamp
recording of Ab-induced transmembrane currents across the plasma
membrane of human neuroblastoma cells (SH-SY5Y). Ab was added
to a final concentration of *10 lM to the extracellular solution. The
applied potential was -80 mV. e Recording from the same cell and
under the same conditions as in (d) but after addition of *2 mM
Zn2? to the extracellular solution. f Control experiment of a whole-
cell recording from a SH-SY5Y cell in the absence of Ab in the
extracellular solution. g Whole-cell planar patch clamp recording
from a primary cortical neuron of a transgenic mouse embryo that
produced human Ab endogenously. The applied potential was
-80 mV. h Effect of the addition of Zn2? on a recording from the
same cell as in (g). i Control experiment with a wild-type cortical
neuron that did not produce Ab
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of events ranged between 0.2 and 1.7 nS in planar lipid
bilayers and between 0.2 and 0.6 nS in both SH-SY5Y cells
and transgenic neurons. Although these conductance values
are not directly comparable (since the ion concentrations
and lipid compositions in the bilayer and cellular experi-
ments could not be matched precisely), this comparison
suggests that the conductance of Ab-induced stepwise ion
flux in bilayers and live cells was on the same order of
magnitude.
In order to minimize the possibility that endogenous,
cellular ion channels would be activated by Ab, we per-
formed all recordings close to the resting membrane
potential (-80 mV) and we added a mixture of ion channel
blockers to the extracellular solution. This mixture
included (final concentration in the extracellular solution):
20 mM tetraethylammonium (TEA) ions to block potas-
sium channels (Forsythe et al. 1992; Mathie et al. 1998;
Tosetti et al. 1998; Guyon et al. 2005), 1 lM tetrodotoxin
to block sodium channels (Forsythe et al. 1992; Toselli
et al. 1996; Guyon et al. 2005), 2 lM nifedipine to block
L-type calcium channels, and 2 lM x-conotoxin to block
N-type calcium channels (McDonald et al. 1994, 1995;
Reeve et al. 1994, 1995; Furukawa et al. 2003; Billups
et al. 2006). Figure 6a shows that Ab-induced ion flux
persisted in the presence of these blockers. Only the
addition of Zn2? caused a significant reduction in
Ab-induced, large-amplitude current fluctuations in these
cells. Since Ab-induced, channel-like ion flux through
artificial bilayers is blocked effectively by Zn2? (Fig. 4b),
the Zn2?-dependent blockage of ion flux shown in Fig. 6a
suggests that Ab is also capable of inducing ion channel-
like ion flux in live cells. These results do not exclude the
Fig. 5 Comparison of short recordings with expanded time axis of
Ab-induced ion flux across planar lipid bilayers, across plasma
membranes of SH-SY5Y cells, and across plasma membranes of
transgenic cortical neurons. a Ab-induced ion flux through a planar
lipid bilayer. The final concentration of Ab was 10 lM (applied
potential -30 mV). b Ab-induced ion flux through membranes of
SH-SY5Y cells. The final concentration of Ab was *10 lM in the
extracellular solution (applied potential -80 mV). Current fluctua-
tions significantly above baseline current noise are indicated with an
asterisk. c Ab-induced ion flux through the plasma membranes of a
cortical neuron that expressed Ab (applied potential -80 mV).
Current fluctuations significantly above baseline current noise are
indicated with an asterisk
Fig. 6 Reduction of Ab-induced ion flux across the plasma mem-
brane of SH-SY5Y cells by Zn2? ions or NA7 peptides. a Effect of
Zn2? (final concentration *2 mM) on Ab-induced ion flux. Note
these recordings were carried out in the presence of a mixture of ion
channel blockers containing 20 mM TEA, 1 lM tetrodotoxin, 2 lM
nifedipine, and 2 lM x-conotoxin; these ion channel blockers did not
affect Ab-induced ion flux but reduced the probability that intrinsic
ion channels may be responsible for the observed current spikes.
Large-amplitude current spikes, i.e. spikes with amplitudes above the
threshold (black solid line), are indicated with an asterisk. The
vertical arrow indicates the time point when Zn2? was added. b
Effect of NA7 peptide (final concentration *100 lM) on Ab-induced
transmembrane ion flux. Large-amplitude current spikes, i.e. spikes
with amplitudes above the threshold (black solid line), are indicated
with an asterisk. The vertical arrow indicates the time point when
NA7 was added. Both recordings were carried out with an applied
potential of -80 mV
Neurotox Res (2009) 16:1–13 9
123
possibility that Ab may activate endogenous cellular
channels; these channels would, however, have to fulfill at
least three characteristics: (1) they would have to be acti-
vated by Ab at the resting potential of -80 mV, (2) they
would have to be insensitive to the cocktail of blockers,
and (3) they would have to be sensitive to Zn2? ions.
Since it is, in principle, possible that Zn2? ions blocked
endogenous, cellular ion channels, we also tested the effect
of a specific blocker of Ab-induced transmembrane ion flux
in these cell experiments. Arispe and coworkers reported
that a peptide called NA7 (corresponding to the amino acid
sequence EVHHQKL of residues 11 to 17 of Ab) is an
effective and specific blocker of Ab-induced, stepwise ion
flux (Simakova and Arispe 2006; Arispe et al. 2007). When
we tested this peptide in SH-SY5Y cells, we found, in three
of four recorded cells, up to a threefold reduction in the
frequency of large-amplitude current events induced by Ab
(Fig. 6b). This result further supports the hypothesis that
Ab can independently induce stepwise (or spike-like) ion
flux across cellular membranes by self-assembly to pores or
by inducing membrane defects.
In conclusion, the work presented here demonstrates that
Ab can cause stepwise transmembrane ion flux through
artificial membranes. The previously postulated membrane
thinning that was reported to lead to gradual increase in
transmembrane ion flux is likely not attributable to Ab, but
instead is due to residues of the solvent HFIP used to
prepare samples of Ab. We found that HFIP is membrane-
active and cytotoxic in the low millimolar range. There-
fore, it is critical to remove HFIP in any amyloid samples
before they are used in membrane or cellular studies. In
addition, we present evidence that Ab is capable of
inducing stepwise transmembrane ion fluctuations in living
cells. Although we cannot rule out the possibility that Ab
activates intrinsic ion channels or ion pumps in cells, the
results presented here suggest that Ab is capable of self-
assembling into structures that either form a pore through
membranes or generate transient defects in membranes.
This conclusion is based on the following four observa-
tions: (1) since Ab clearly forms stepwise ion fluctuations
in planar lipid bilayers, it is plausible that it can form
similar transmembrane ion fluctuations in cellular mem-
branes. (2) Ab-induced stepwise ion fluctuations in cellular
membranes occur at the resting potential of cells (where the
activity of intrinsic ion channels is minimal) and persist in
the presence of molecules that block the most common ion
channel proteins. (3) In contrast, these Ab-induced step-
wise ion fluctuations in cellular membranes are blocked
by Zn2? ions and a heptapeptide derived from the sequence
of Ab (both Zn2? ions and this heptapeptide block
Ab-induced, stepwise ion flux through artificial bilayers;
Arispe et al. 2007). (4) Finally, Ab-induced stepwise ion
fluctuations in cellular membranes resemble Ab-induced
stepwise ion fluctuations in artificial membranes with
regards to their frequency and amplitude of current events.
Based on these observations, we conclude that stepwise ion
flux through Ab-induced pores or membrane defects could
contribute to the disruption of Ca2? homeostasis that is
commonly associated with Alzheimer’s disease.
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